A Novel Series of Tacrine-Selegiline Hybrids with Cholinesterase and Monoamine Oxidase Inhibition Activities for the Treatment of Alzheimer'S Disease

Chuanjun Lu,Qi Zhou,Jun Yan,Zhiyun Du,Ling Huang,Xingshu Li

DOI: https://doi.org/10.1016/j.ejmech.2013.01.039

IF: 7.088

2013-01-01

European Journal of Medicinal Chemistry

Abstract:A novel series of tacrine-selegiline hybrids was synthesised and evaluated for application as inhibitors of cholinesterase (AChE/BuChE) and monoamine oxidase (MAO-A/B). The results demonstrate that most of the synthesised compounds exhibit high inhibitory activity. Among these compounds, compound 8g provided a good balance of activity towards all targets (with IC50 values of 22.6 nM, 9.37 nM, 0.3724 mu M, and 0.1810 mu M for AChE, BuChE, MAO-A and MAO-B, respectively). These results indicated that 8g has the potential to be a multi-functional candidate for Alzheimer's disease. (C) 2013 Elsevier Masson SAS. All rights reserved.